Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 164, Issue 5, pp 673–675 | Cite as

Decrease in Bcl-2 Protein Level during the Development of Lewis Carcinosarcome

  • E. M. Mil’
  • V. N. Erokhin
  • V. I. Binyukov
  • V A. Semenov
  • A. A. Albantova
  • S. V. Blokhina
Article
  • 14 Downloads

We studied the development of Lewis carcinoma and possible antitumor effect of preliminary administered antioxidant anphen. The tumor was intramuscularly transplanted to C57Bl×DBA mice (7×106 cells per mouse). According to immunoblotting results, the content of anti-apoptotic Bcl-2 protein steadily decreased starting from post-transplantation day 11. In few days, its content decreased by 15-20% and soon the animals died. After administration of anphen, the content of Bcl-2 decreased more rapidly than in the control. Atomic force microscopy revealed a decrease in the mean volume of erythrocytes and then increase in this parameter at the terminal stage of tumor growth. These findings suggest that anphen does not affect the tumor growth rate and mouse lifespan, but enhances apoptosis of blood cells of animals with Lewis carcinoma at the terminal stages of tumor growth.

Key Words

Lewis carcinosarcoma Bcl-2 protein anphen 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Binyukov VI, Alekseeva OM, Mil EM, Albantova AA, Goloshchapov AN, Burlakova EB, Fattachov SG, Konovalov AI. Investigation of the influence of phenosan, ichphan-10, and melafen on red blood cells in vivo by atomic force microscopy. Doklady Biochem. Biophysics. 2011;441(1):245-247.CrossRefGoogle Scholar
  2. 2.
    Volod’kin AA, Erokhin VN, Burlakova EB, Zaikov GE Lomakin SM. The structure and biological properties of sodium and potassium 1-carboxy-1-(N-methylamide)-2-(3,5-di-tert-butyl-4’-hydroxylphenyl)-propanates. Khim. Fizika. 2013;32(2):66. Russian.Google Scholar
  3. 3.
    Zhizhina GP, Zavarykina TP, Mil’ EM, Burlakova EB. Changes in structural characteristics of splenic DNA in mice after administration of phenosan and whole-body γ-radiation in a low dose with low power. Radiats. Biol. Radioekol. 2007. Т.47(4):414-422. Russian.Google Scholar
  4. 4.
    Mil’ EM, Albantova AA, Burlakova EB. Effect of antioxidant phenosan and irradiation in a low dose on the content of p53 and Bcl-2 proteins in mice of different lines. Radiats. Biol. Radioekol. 2010;50(1):58-64. Russian.Google Scholar
  5. 5.
    Mil’ EM, Kasparov VV, Borisova OA, Myshliakova OV, Erokhin VN. Changes in levels of p53 protein, immunoglobulin L-chains, and iron complexes in mice of leukosis strain AKR following low dose irradiat ion. Biofizika. 2001;46(2):346-352.PubMedGoogle Scholar
  6. 6.
    Amstad PA, Liu H, Ichimiya M, Berezesky IK, Trump BF, Buhimschi IA, Gutierrez PL. BCL-2 is involved in preventing oxidant_induced cell death and in decreasing oxygen radical production. Redox Report. 2001.Vol. 6(6):351-362.CrossRefPubMedGoogle Scholar
  7. 7.
    Kok SH, Hong CY, Lin SK, Lee JJ, Chiang CP, Kuo MY. Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma. Оral. Oncol. 2007;43(7):639-647.Google Scholar
  8. 8.
    Laudanski J, Niklinska W, Burzykowski T, Chyczewski L, Niklinski J. Prognostic significance of p53 and bcl_2 abnormalities in operable non_small cell lung cancer. Eur. Respir. J. 2001;17(4):660-666.CrossRefPubMedGoogle Scholar
  9. 9.
    Ulukus EC, Kargi HA, Sis B, Lebe B, Oztop I, Akkoclu A, Onen A, Sanli A. Survivin expression in non small-cell lung carcinomas: correlation with apoptosis and other apoptosisrelated proteins, clinicopathologic prognostic factors and prognosis. Appl. Immunohistochem. Mol. Morphol. 2007;15(1):31-37.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • E. M. Mil’
    • 1
  • V. N. Erokhin
    • 1
  • V. I. Binyukov
    • 1
  • V A. Semenov
    • 1
  • A. A. Albantova
    • 1
  • S. V. Blokhina
    • 2
  1. 1.N. M. Emanuel Institute of Biochemical PhysicsRussian Academy of SciencesMoscowRussia
  2. 2.Institute of Problems of Chemical PhysicsRussian Academy of SciencesMoscowRussia

Personalised recommendations